<VariationArchive VariationID="1705082" VariationName="NM_000400.4(ERCC2):c.2141_2148del (p.Val714fs)" VariationType="Deletion" Accession="VCV001705082" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-29" DateCreated="2022-09-17" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1699614" VariationID="1705082">
      <GeneList>
        <Gene Symbol="ERCC2" FullName="ERCC excision repair 2, TFIIH core complex helicase subunit" GeneID="2068" HGNC_ID="HGNC:3434" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="45349837" stop="45370573" display_start="45349837" display_stop="45370573" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="45854648" stop="45873844" display_start="45854648" display_stop="45873844" Strand="-" />
          </Location>
          <OMIM>126340</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000400.4(ERCC2):c.2141_2148del (p.Val714fs)</Name>
      <CanonicalSPDI>NC_000019.10:45352250:CACCTGGACACC:CACC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="45352251" stop="45352258" display_start="45352251" display_stop="45352258" variantLength="8" positionVCF="45352250" referenceAlleleVCF="CCACCTGGA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="45855509" stop="45855516" display_start="45855509" display_stop="45855516" variantLength="8" positionVCF="45855508" referenceAlleleVCF="CCACCTGGA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>V714fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.45352255_45352262del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.45352255_45352262del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000400.4" sequenceAccession="NM_000400" sequenceVersion="4" change="c.2141_2148del" MANESelect="true">
            <Expression>NM_000400.4:c.2141_2148del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000391.1" sequenceAccession="NP_000391" sequenceVersion="1" change="p.Val714fs">
            <Expression>NP_000391.1:p.Val714fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.45855513_45855520del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.45855513_45855520del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007067.2" sequenceAccession="NG_007067" sequenceVersion="2" change="g.23330_23337del">
            <Expression>NG_007067.2:g.23330_23337del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000400.3" sequenceAccession="NM_000400" sequenceVersion="3" change="c.2141_2148delTCCAGGTG">
            <Expression>NM_000400.3:c.2141_2148delTCCAGGTG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_461" sequenceAccession="LRG_461">
            <Expression>LRG_461:g.23330_23337del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_461t1" sequenceAccession="LRG_461t1">
            <Expression>LRG_461t1:c.2137_2144del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_461p1" sequenceAccession="LRG_461p1" change="p.Val714Glyfs">
            <Expression>LRG_461p1:p.Val714Glyfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000400.4(ERCC2):c.2141_2148del (p.Val714fs) AND Xeroderma pigmentosum" Accession="RCV002283407" Version="1">
        <ClassifiedConditionList TraitSetID="7951">
          <ClassifiedCondition DB="MedGen" ID="C0043346">Xeroderma pigmentosum</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-12" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000400.4(ERCC2):c.2141_2148del (p.Val714fs) AND not provided" Accession="RCV003679090" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-01-08" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-09-17" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">31282071</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31803976</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-17">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="7951" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="7021" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum</ElementValue>
                <XRef ID="Xeroderma+pigmentosum/7564" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019600" DB="MONDO" />
                <XRef ID="44600005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosa</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7910" />
                <XRef ID="7910" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="910" DB="Orphanet" />
              <XRef ID="C0043346" DB="MedGen" />
              <XRef ID="MONDO:0019600" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5027732" SubmissionDate="2022-09-14" DateLastUpdated="2022-09-17" DateCreated="2022-09-17">
        <ClinVarSubmissionID localKey="NM_000400.3:c.2141_2148delTCCAGGTG|MedGen:C0043346" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002571986" DateUpdated="2022-09-17" DateCreated="2022-09-17" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Variant summary: ERCC2 c.2141_2148delTCCAGGTG (p.Val714GlyfsX57) causes a frameshift which results in an extension of the protein. While this variant is not anticipated to result in nonsense mediated decay, it is predicted to disrupt the last 47 amino acids of the protein and extend the protein by approximately 11 additional amino acid residues. Other protein-extending variants have been reported as pathogenic in ClinVar (variation ID: 1028729). The variant allele was found at a frequency of 4e-06 in 251234 control chromosomes. To our knowledge, no occurrence of c.2141_2148delTCCAGGTG in individuals affected with Xeroderma Pigmentosum and no experimental evidence demonstrating its impact on protein function have been reported. Other variants within the disrupted region of the protein have been classified internally as pathogenic (example: p.Arg722Trp), suggesting this region of the protein is clinically significant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000400.3:c.2141_2148delTCCAGGTG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0043346" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12061022</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8214679" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="18175852|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004425183" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31282071</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31803976</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the ERCC2 protein in which other variant(s) (p.Arg722Trp) have been determined to be pathogenic (PMID: 31282071, 31803976). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1705082). This variant has not been reported in the literature in individuals affected with ERCC2-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change results in a frameshift in the ERCC2 gene (p.Val714Glyfs*57). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 47 amino acid(s) of the ERCC2 protein and extend the protein by 9 additional amino acid residues.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.45855509_45855516del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8214679" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5027732" TraitType="Disease" MappingType="XRef" MappingValue="C0043346" MappingRef="MedGen">
        <MedGen CUI="C0043346" Name="Xeroderma pigmentosum" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

